Guardant Health (GH) Cash from Financing Activities (2017 - 2026)
Guardant Health's Cash from Financing Activities history spans 9 years, with the latest figure at $732.0 million for Q4 2025.
- On a quarterly basis, Cash from Financing Activities rose 25041.33% to $732.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $671.1 million, a 67482.83% increase, with the full-year FY2025 number at $671.1 million, up 67482.83% from a year prior.
- Cash from Financing Activities hit $732.0 million in Q4 2025 for Guardant Health, up from $4.3 million in the prior quarter.
- Over the last five years, Cash from Financing Activities for GH hit a ceiling of $732.0 million in Q4 2025 and a floor of -$172.1 million in Q2 2022.
- Historically, Cash from Financing Activities has averaged $44.6 million across 5 years, with a median of $806000.0 in 2022.
- Biggest five-year swings in Cash from Financing Activities: tumbled 7016.67% in 2023 and later skyrocketed 25041.33% in 2025.
- Tracing GH's Cash from Financing Activities over 5 years: stood at $3.8 million in 2021, then crashed by 38.68% to $2.3 million in 2022, then surged by 3807.16% to $90.6 million in 2023, then tumbled by 103.24% to -$2.9 million in 2024, then skyrocketed by 25041.33% to $732.0 million in 2025.
- Business Quant data shows Cash from Financing Activities for GH at $732.0 million in Q4 2025, $4.3 million in Q3 2025, and $1.6 million in Q2 2025.